SAREUM HOLDINGS PLC
Clinical-stage company developing kinase inhibitors for autoimmune diseases and cancer.
SAR | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMC3RJ87
- LEI:
- 213800PKERN2DY8FFM72
- Country:
- United Kingdom
- Address:
- UNIT 2A, CB22 3FX CAMBRIDGE
- Website:
- https://www.sareum.com/
- Sector:
- Manufacturing
Description
Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-05 08:00 |
Director Dealing
|
English | 28.5 KB | ||
| 2023-09-04 08:00 |
Dosing of first subjects in MAD Phase 1a trial
|
English | 14.6 KB | ||
| 2023-08-16 08:00 |
Update on financial and operational progress
|
English | 20.3 KB | ||
| 2023-08-03 08:00 |
Equity Prepayment Facility of up to £5 million
|
English | 31.0 KB | ||
| 2023-06-26 08:00 |
Sareum Announces Two New Granted Patents
|
English | 15.5 KB | ||
| 2023-06-06 08:00 |
Dosing commences in Phase 1a trial of SDC-801
|
English | 14.9 KB | ||
| 2023-05-18 08:00 |
Phase 1a clinical trial for SDC-1801
|
English | 12.7 KB | ||
| 2023-05-05 10:20 |
Approval to initiate Phase 1 clinical trial
|
English | 13.1 KB | ||
| 2023-03-22 08:00 |
Half-Year Report
|
English | 124.8 KB | ||
| 2023-03-15 08:01 |
Update on SDC-1801
|
English | 14.4 KB | ||
| 2023-03-15 08:00 |
Notice of Half-Year Results
|
English | 10.9 KB | ||
| 2023-03-06 08:00 |
Update on SRA737
|
English | 11.8 KB | ||
| 2022-12-29 16:14 |
Director/PDMR Shareholding
|
English | 28.2 KB | ||
| 2022-12-16 16:29 |
Results of AGM
|
English | 21.3 KB | ||
| 2022-12-16 08:00 |
AGM Statement
|
English | 16.8 KB |
Automate Your Workflow. Get a real-time feed of all SAREUM HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SAREUM HOLDINGS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAREUM HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
